Get started
Author

Katri S. Selander

Observed names: K S Selander, K Selander, K. S. Selander, K. Selander, K.S. Selander, KATRI S. SELANDER, Katri S Selander, Katri Selander, Selander, Katri, Selander, Katri S.
Observed institutions: University of Alabama at Birmingham Hospital, University of Turku, The University of Texas at San Antonio Health Science Center, Duke University, University of Alabama, Lund University, Oulu University Hospital, University of Alabama at Birmingham, Kuopio University Hospital, Lapland Central Hospital, Birmingham VA Medical Center, Duke Medical Center, South Texas Veterans Health Care System, Østfold Hospital Trust, UAB Medicine, University of Oulu
ORCID: 0000-0003-4812-294X
Observed ORCID: 0000-0003-4812-294X
OpenAlex ID: A5049106949
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999 · Juan Juan Yin, Katri Selander, et al. · Journal of Clinical Investigation · 986
PDF
Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways
2002 · Sanna-Maria Käkönen, Katri S. Selander, et al. · Journal of Biological Chemistry · 276
PDF
Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.
1996 · K S Selander, J Mönkkönen, et al. · Molecular Pharmacology · 237
Toll-Like Receptor 9 Agonists Promote Cellular Invasion by Increasing Matrix Metalloproteinase Activity
2006 · Melinda A. Merrell, Joanna M. Ilvesaro, et al. · Molecular Cancer Research · 223
Long-term Controlled Trial With Diphosphonate in Patients With Osteolytic Bone Metastases
1983 · I. Elomaa, C. Blomqvist, et al. · The Lancet · 210
Toll like receptor‐9 agonists stimulate prostate cancer invasion in vitro
2007 · Joanna M. Ilvesaro, Melinda A. Merrell, et al. · The Prostate · 160
Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases
2008 · Guojun Bu, Wenyan Lu, et al. · International Journal of Cancer · 126
PDF
The effects of bisphosphonates on the resorption cycle of isolated osteoclasts
1994 · K. Selander, P. Lehenkari, et al. · Calcified Tissue International · 117
Alendronate Disturbs Vesicular Trafficking in Osteoclasts
2002 · A. Alakangas, K. Selander, et al. · Calcified Tissue International · 101
Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases
2007 · Katri S. Selander, David A. Brown, et al. · Cancer Epidemiology Biomarkers & Prevention · 93
PDF
Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy
2004 · Katri S. Selander, Li Li, et al. · Cancer Research · 91
Toll-Like Receptor 9 Mediates CpG Oligonucleotide–Induced Cellular Invasion
2008 · Joanna M. Ilvesaro, Melinda A. Merrell, et al. · Molecular Cancer Research · 81
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
2012 · Johanna Tuomela, Jouko Sandholm, et al. · Breast Cancer Research and Treatment · 76
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
2021 · Nataliia Petruk, Sanni Tuominen, et al. · Scientific Reports · 75
PDF
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma
2011 · Joonas H Kauppila, Heikki Takala, et al. · Histopathology · 72
Breast cancer cells with inhibition of p38<>α have decreased MMP-9 activity and exhibit decreased bone metastasis in mice
2004 · Catalina Suarez-Cuervo, Melinda A. Merrell, et al. · Clinical & Experimental Metastasis · 68
Expression of toll‐like receptor‐9 is increased in poorly differentiated prostate tumors
2010 · Marja‐Riitta Väisänen, Timo Väisänen, et al. · The Prostate · 65
Expression of macrophage inhibitory cytokine‐1 in prostate cancer bone metastases induces osteoclast activation and weight loss
2009 · Savita Wakchoure, Telisha Millender Swain, et al. · The Prostate · 62
Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts
2006 · Hannu-Ville Leskelä, Anu Olkku, et al. · Bone · 60
Calcitonin promotes osteoclast survival in vitro
1996 · Katri S. Selander, Pirkko L. Härkönen, et al. · Molecular and Cellular Endocrinology · 59
Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro
2007 · Maarit Kellinsalmi, Vilhelmiina Parikka, et al. · European Journal of Pharmacology · 57
Tumor infiltrating CD8+T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma
2015 · Mikko Mella, Joonas H Kauppila, et al. · OncoImmunology · 53
PDF
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
2011 · Hanna Ronkainen, Pasi Hirvikoski, et al. · Journal of Experimental & Clinical Cancer Research · 53
PDF
Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13
2010 · S. Nurmenniemi, P. Kuvaja, et al. · Experimental Cell Research · 52
Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
1998 · T A Hentunen, S V Reddy, et al. · Journal of Clinical Investigation · 52
PDF
Works count: 88
Citation count: 4,335
H-index: 36
I10-index: 50
Year
Topic
Type